<DOC>
	<DOCNO>NCT01105338</DOCNO>
	<brief_summary>RATIONALE : Lycopene green tea may stop delay development recurrent prostate cancer patient treat prostate cancer . It yet know whether lycopene green tea may effective prevent prostate cancer . PURPOSE : This randomized phase II trial study lycopene see well work compare green tea prevent prostate cancer patient previously enrol ProtecT trial</brief_summary>
	<brief_title>Lycopene Green Tea Men Risk Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To assess serum lycopene epigallocatechin-3-gallate ( green tea ) level 6 month follow randomization patient prostate cancer previously enrol ProtecT Secondary - To evaluate trial recruitment randomization rate patient treated regimen . - To evaluate intervention tolerability patient treat regimen . - To evaluate compliance patient treat regimen . - To evaluate trial retention patient treat regimen . - To assess PSA value patient treat regimen . - To evaluate dietary compliance recommendation patient treat regimen . - To assess weight body mass index patient treat regimen . - To evaluate attitude view men spouse dietary modification participation long-term study . OUTLINE : Patients stratify accord PSA test level obtain ProtecT study recruitment clinic ( &lt; 3.0 ng/mL vs 3.0-19.99 ng/mL ) . Patients randomize 1 2 treatment arm .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>Inclusion criterion : PSA level 2.02.95 ng/mL OR PSA level â‰¥ 3.0 ng/mL negative biopsy No major comorbidities No cancer prior prostate malignancy No history allergic reaction green tea lycopenecontaining product , include guava watermelon Exclusion criterion : No concurrent finasteride dutasteride</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>prostate cancer</keyword>
</DOC>